Geodesic launches NovaDDE platform targeting AGI for drug discovery
QuanquanGu · x · 2026-09-10
- Geodesic, founded by UCLA professor Quanquan Gu's team, is launching an AI-native platform for protein therapeutics, positioning itself as "building AGI for drug discovery" to find the shortest path from biology to medicines.
- First releases include NovaDDE and NovaAtom-Lite-Preview; early-access users praise its protein design capabilities for drug discovery and synthetic biology.
Related event: UCLA's Quanquan Gu founds Geodesic to build AGI for drug discovery(4 posts)→
More from Apps
- Paradigm Launches Envoys: Your Claude Code and Codex on Your Research Graph, Free — tensorqt · 2026-10-27
- Riverside Agents launches: auto-edits recordings into ready-to-post clips with hooks, B-roll and captions — dr_cintas · 2026-10-27
- AXL launches remote MCP server exposing 1,284 sales and marketing APIs to Claude and Codex — EdTech_Padre · 2026-10-27
- A reusable viral content writing prompt template for AI agents — heyshrutimishra · 2026-10-27
- Datology webinar: Curation Studio matched top data baselines with under 20% compute — josh_wills · 2026-10-27
- Vercel adds 2FA confirmation and email re-login for sensitive dashboard actions — cramforce · 2026-10-27